New Delhi [India], May 16 (ANI): Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufa
Mumbai (Maharashtra) [India], May 15 (ANI): Speciality chemicals manufacturer Rossari Biotech has posted 37 per cent increase in its revenues from operations during the quarter ended March at Rs 218 crore as against Rs 160 crore in the year-ago period.
Bengaluru (Karnataka) [India], May 14 (ANI): Karnataka will soon have a manufacturing plant of Bharat Biotech's Covaxin in Maluru industrial area, near Kolara district, said Deputy Chief Minister and State COVID task force head Dr C N Ashwatha Narayana on Friday.
New Delhi [India], May 13 (ANI): Delhi Health Minister Satyendar Jain on Thursday said that he has suggested to the Union Health Ministry that the Central government should float a single global tender instead of various states to purchase COVID-19 vaccines.
New Delhi [India], May 13 (ANI): Amid the reports of vaccine shortage from various state, Central government and Hyderabad based Bharat Biotech is willing to invite other companies who want to produce COVAXIN to increase the production, said NITI Aayog member, Dr VK Paul, on Thursday.
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
New Delhi [India], May 12 (ANI): Amid the reports of shortage of Bharat Biotech's COVID-19 vaccine, the Centre on Wednesday said it will double the current production capacity of COVAXIN by May-June and then increase it to nearly six to seven folds by July-August. The government of India sai
New Delhi [India], May 12 (ANI): The Delhi government has been forced to shut down 100 vaccination sites over 17 schools that administered Bharat Biotech's COVAXIN vaccine due to a dearth of supply from the manufacturer, Delhi Deputy Chief Minister Manish Sisodia said on Wednesday.
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
New Delhi [India], May 11 (ANI): Bharat Biotech on Tuesday informed that the firm has been supplying its COVID-19 vaccine Covaxin directly to 18 states since May 1.
Washington [US], May 8 (ANI): During a recent study EMBL scientists combined artificial intelligence (AI) algorithms with two cutting-edge microscopy techniques, an advancement that shortens the time for image processing from days to mere seconds while ensuring that the resulting images are
New Delhi [India], May 7 (ANI/ThePRTree): Chief Executive Officer at Fermenta Biotech Limited (FBL), Prashant Nagre, gets appointed as the new Managing Director of the company. The announcement was done by Krishna Datla, Promoter and Managing Director at FBL.